ACP
Altitude Crest Partners Portfolio holdings
AUM
$234M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$234M
AUM Growth
+$84.1M
(+56%)
Holding
34
Top Buys
| 1 | +$16.7M | |
| 2 | +$11.2M | |
| 3 | +$10.3M | |
| 4 |
Structure Therapeutics
GPCR
|
+$8.65M |
| 5 |
Apellis Pharmaceuticals
APLS
|
+$8.61M |
Top Sells
| 1 | +$11.2M | |
| 2 | +$11M | |
| 3 | +$7.33M | |
| 4 |
BridgeBio Pharma
BBIO
|
+$4.85M |
| 5 |
Roivant Sciences
ROIV
|
+$3.81M |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zymeworks
ZYME
$1.9B
| $1.53M | 0.66% |
+145,581
|
|
||
27
Metagenomi Therapeutics
MGX
$50.8M
| $1.41M | 0.6% |
+133,333
|
|
||
|
TRML
28
DELISTED
Tourmaline Bio
TRML
| $1.09M | 0.46% |
+47,400
|
|
||
29
Alnylam Pharmaceuticals
ALNY
$42.2B
| $29.9K | 0.01% |
+200
|
|
||
30
Surrozen Inc Warrant
SRZNW
$54.6K
| $12.5K | 0.01% |
384,573
|
|
||
|
EXAS
31
DELISTED
Exact Sciences
EXAS
| – | – |
-99,130
|
|
||
|
AMAM
32
DELISTED
Ambrx Biopharma Inc
AMAM
| – | – |
-43,100
|
|
||
33
argenx
ARGX
$47B
| – | – |
-29,500
|
|
||
34
BioMarin Pharmaceuticals
BMRN
$10.8B
| – | – |
-114,042
|
|